Immuno Oncology Assays Market Size, Share, Growth Report 2030

The report covers a forecast and an analysis of the immuno oncology assays market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the immuno oncology assays market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immuno oncology assays market on a global and regional level.

In order to give the users of this report a comprehensive view of the immuno oncology assays market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the immuno oncology assays market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the immuno oncology assays market on a global and regional basis.

The study provides a decisive view of the immuno oncology assays market by segmenting it based on product, assay, technology, indication, application, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some major players operating in the global immuno oncology assays market include Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics, Nanostring Technologies, Illumina, Foundation Medicine, Sartorius, Qiagen, HTG Molecular Diagnostics, PerkinElmer, and Merck.

Report Scope:

This report segments the global immuno oncology assays market into:

Global Immuno Oncology Assays Market: By Product

• Consumables
• Software

Global Immuno Oncology Assays Market: By Assay

• Cell Proliferation
• Cell Migration and Invasion
• Phagocytosis
• Immune Cell Killing
• Other

Global Immuno Oncology Assays Market: By Technology

• PCR
• Immunoassay
• NGS
• Flow Cytometry
• Others

Global Immuno Oncology Assays Market: By Indication

• Lung Cancer
• Colorectal Cancer
• Melanoma
• Bladder Cancer
• Other Cancers

Global Immuno Oncology Assays Market: By Application

• Research Applications
• Clinical Diagnostics

Global Immuno Oncology Assays Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa